Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (331-340 of 395) with videos related to

Pageof 40
Sort By:
Rheumatology International|October 8, 2003
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritisPiercarlo Sarzi-Puttini, Enzo D'Ingianna, Mario Fumagalli, et al.
Clinical and Experimental Rheumatology|July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registryMaria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
Seminars in Arthritis and Rheumatism|April 24, 2026
Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibilitySimone Longhino, Maria Teresa Rizzo, Valeria Manfrè, et al.
Frontiers in Genetics|September 16, 2024
Corrigendum: Evidence for a genetic contribution to the ossification of spinal ligaments in ossification of posterior longitudinal ligament and diffuse idiopathic skeletal hyperostosis: a narrative reviewAna Rita Couto, Bruna Parreira, Deborah M Power, et al.
Frontiers in Genetics|October 24, 2022
Evidence for a genetic contribution to the ossification of spinal ligaments in Ossification of Posterior Longitudinal Ligament and Diffuse idiopathic skeletal hyperostosis: A narrative reviewAna Rita Couto, Bruna Parreira, Deborah M Power, et al.
The Journal of Rheumatology|January 17, 2012
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgiaAntonio Marchesoni, Fabiola Atzeni, Antonio Spadaro, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registriesVeronica Codullo, Florenzo Iannone, Luigi Sinigaglia, et al.
International Journal of Molecular Sciences|October 14, 2023
Osteoimmunology of SpondyloarthritisAngelo Fassio, Fabiola Atzeni, Maurizio Rossini, et al.
Clinical Rheumatology|July 16, 2016
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function abilityFlorenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, et al.
Autoimmunity Reviews|October 27, 2010
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritisMartina Fabris, Luca Quartuccio, Sandra Lombardi, et al.
Pageof 40

Showing results (331-340 of 395) with videos related to

Sort By:
Pageof 40
Rheumatology International|October 8, 2003
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritisPiercarlo Sarzi-Puttini, Enzo D'Ingianna, Mario Fumagalli, et al.
Clinical and Experimental Rheumatology|July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registryMaria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
Seminars in Arthritis and Rheumatism|April 24, 2026
Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibilitySimone Longhino, Maria Teresa Rizzo, Valeria Manfrè, et al.
Frontiers in Genetics|September 16, 2024
Corrigendum: Evidence for a genetic contribution to the ossification of spinal ligaments in ossification of posterior longitudinal ligament and diffuse idiopathic skeletal hyperostosis: a narrative reviewAna Rita Couto, Bruna Parreira, Deborah M Power, et al.
Frontiers in Genetics|October 24, 2022
Evidence for a genetic contribution to the ossification of spinal ligaments in Ossification of Posterior Longitudinal Ligament and Diffuse idiopathic skeletal hyperostosis: A narrative reviewAna Rita Couto, Bruna Parreira, Deborah M Power, et al.
The Journal of Rheumatology|January 17, 2012
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgiaAntonio Marchesoni, Fabiola Atzeni, Antonio Spadaro, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registriesVeronica Codullo, Florenzo Iannone, Luigi Sinigaglia, et al.
International Journal of Molecular Sciences|October 14, 2023
Osteoimmunology of SpondyloarthritisAngelo Fassio, Fabiola Atzeni, Maurizio Rossini, et al.
Clinical Rheumatology|July 16, 2016
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function abilityFlorenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, et al.
Autoimmunity Reviews|October 27, 2010
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritisMartina Fabris, Luca Quartuccio, Sandra Lombardi, et al.
Pageof 40